广痛消泡沫气雾剂治疗肛门水肿模型的实验研究及炎性痔的临床观察
摘要
1目的
广痛消泡沫气雾剂是导师赵宝明教授开发研制,前期研究已表明该剂型在治疗混合痔、肛裂等肛肠疾病,既有中医药特色,又有外治优势,其剂型在国外也被广泛应用,该药止痛、解痉作用机理已得到证实。混合痔引起的肛门水肿在临床多见,患者痛苦症状明显,急待医者解决。本研究目的通过利用巴豆油致大鼠肛门水肿模型,研究并探讨广痛消泡沫气雾剂对此模型的抗炎、消肿、止痛作用及机制,并从临床观察门诊治疗和术后病理组织两方面,分析探讨广痛消泡沫剂对炎性痔临床症状的治疗作用,以及抑制炎性细胞因子和炎症反应的作用机制。
2方法
本研究分为三部分。第一部分为文献研究,首先通过归纳混合痔引起肛门水肿的中医病因病机,从宏观上探讨痔的发病学说以及水肿与血管内皮功能的微观认识,总结目前中西医非手术疗法治疗炎性痔的研究进展,从中找到广痛消泡沫剂消肿作用的研究切入点及相关因子的意义。其次以中药外治法治疗炎性痔为主题,进行Meta分析研究,探讨该方法的有效性及安全性。最后通过总结导师赵宝明教授临床经验,回顾该剂型的前期以及汇报本人跟师学习的体会。第二部分为动物实验部分,主要包括实验一巴豆油致SD大鼠肛门水肿模型的建立,实验二主要观察广痛消泡沫气雾剂对大鼠肛门水肿模型的止痛作用,实验三采用酶联免疫吸附法测定TNF-a和IL-6,实验四免疫组化法测iNOS,从以上四方面来证实广痛消泡沫气雾剂对大鼠肛门水肿有抗炎、止痛、消肿的作用。第三部分为临床观察部分,首先通过随机对照、单盲观察广痛消泡沫气雾剂治疗炎性痔门诊患者疗效,用药前后症状积分的改善情况,其次对炎性痔患者术前给予广痛消泡沫气雾剂治疗,术后用免疫组化法测定痔组织内iNOS、TNF-α、IL-6含量的变化等,客观反映该剂型的抗炎作用机制。
3结果
3.1动物实验结果
3.1.1巴豆油致大鼠肛门水肿模型
通过巴豆油致SD大鼠肛门肿胀的形态改变和病理组织切片,提示SD大鼠肛门肿胀模型符合急性炎症改变,与痔疮急性发作时炎性改变相似。广痛消泡沫气雾剂组的组织切片中肛门近端黏膜上皮及腺体从造模后缺失到给药后逐渐修复完整,粘膜下层水肿、血管充血、扩张程度也较模型组明显减轻。
3.1.2广痛消泡沫气雾剂对大鼠肛门水肿模型的止痛作用
各组造模前6h机械痛阈值和热痛阈值具有可比性。
造模后6h各组间机械痛阈值比较P<0.05,差异具有统计学意义,提示各组间有差异。阳性对照组、广痛消泡沫气雾剂大剂量组、中剂量组给药前后机械性收缩反射阈值变化明显,且用药前后比较,P<0.05,差异显著并具有统计学意义。末次给药6h后MWT值均正态分布,且方差齐。末次给药后6h模型组、阴性对照组、广痛消泡沫气雾剂大剂量组和小剂量组与空白组MWT值比较,P<0.05,差异具有统计学意义；阳性性对照组与广痛消中剂量组比较,P>0.05,差异无统计学意义。
造模前6h各组间TWL值比较P>0.05,无统计学意义,提示各组热痛阈值具有可比性。阳性对照组、广痛消泡沫气雾剂大剂量组和中剂量组给药前后热痛阈值变化明显,P<0.05,差异显著并具有统计学意义。末次给药后6h,空白组、广痛消大剂量组与阳性对照组比较,P>0.05,差异无统计学意义。
3.1.3酶联免疫吸附法测定TNF-a和IL-6含量
通过Elisa法测定动物肛周组织及直肠下段,正常组与模型组中’TNF-a和IL-6含量有明显差异,P<0.05,具有统计学意义,说明巴豆油致SD大鼠肛门水肿模型符合炎症改变。广痛消泡沫气雾剂各组与消炎痛栓组的TNF-a和IL-6含量无明显差异,P>0.05,差异无统计学意义；广痛消泡沫气雾剂各组之间两种因子的含量两两比较无明显差异,P>0.05,暂不能说明各个剂量无量效关系。
3.1.4免疫组化法iNOS的表达
通过免疫组化法观察大鼠肛周组织及直肠下段,广痛消泡沫气雾剂各剂量组iNOS的表达均少于模型组,较阳性对照组增多,以小剂量组增多明显。测定免疫组化染色光密度值,广痛消泡沫气雾剂各剂量组与模型组、空白组无统计学差异,P>0.05,暂不能说明广痛消泡沫气雾剂对iNOS的表达无抑制作用。
3.2临床观察结果
3.2.1门诊患者症状积分改变
三组患者用药前性别、年龄、病程、混合痔分期,以及用药前疼痛、便血、坠痛、脱垂、痔黏膜糜烂情况、痔肿胀大小情况均具有可比性。用药治疗7天后,广痛消组和消炎痛组疼痛VAS积分明显降低；广痛消泡沫气雾剂组用药前便血症状积分最高,用药后便血积分最低；广痛消组坠痛积分下降幅度明显且第7天时积分最低；广痛消组对痔核黏膜的修复作用明显优于其它两组,普济痔疮栓对痔核表面的改善作用优于消炎痛栓组；广痛消泡沫气雾剂对痔核大小的消肿作用起效时间较消炎痛栓组慢,对痔核肿胀面积的改变与消炎痛栓组结果相一致,差异无统计学意义。三组总体有效率广痛消组(98.5%)明显高于消炎痛栓组(96.8%)和普济痔疮栓组(90.1%)。
3.2.2免疫组化法测定IL-6、TNF-a、iNOS的表达
利用免疫组化法观察水肿痔组织内的IL-6、TNF-a、iNOS的表达：三组图片中阳性表达最多的为空白组,表达较少的为广痛消泡沫气雾剂组,最少的是消炎痛栓组。广痛消泡沫气雾剂组与消炎痛栓组IL-6的免疫组化染色光密度值比较,P>0.05, TNF-a和iNOS的免疫组化染色光密度值比较P<0.05；与空白组IL-6、iNOS的免疫组化染色光密度值比较,P>0.05, TNF-a的OD值比较P<0.05。
4结论
广痛消泡沫气雾剂对于治疗巴豆油致SD大鼠肛门水肿有确切的抗炎、消肿、止痛的作用。临床观察广痛泡沫气雾剂对炎性痔引起的疼痛、便血等症状有明显的止痛、消肿、修复痔核黏膜、提升痔核位置的作用,总体效果明显优于消炎痛栓组和普济痔疮栓组。而且中药组在改善便血和修复痔核黏膜方面明显优于消炎痛栓组。
广痛消泡沫气雾剂抗炎消肿、止痛的作用机制主要是该药能够降低TNF-a和IL-6的表达,抑制了iNOS的激活,减少NO的释放,从而达到抗炎、消肿、止痛的目的,其量效关系值得进一步探讨。
GuangTongXiao Foam Aerosol(GTX) is invented by professor Zhao Baoming. Previous studies have shown the dosage form in the treatment of mixed hemorrhoids, anal fissure and other anorectal diseases has both features of traditional Chinese medicine and external treatment advantage. The dosage form has been widely used in foreign countries. GTX's mechanism of relieving pain and spasmolysis has been confirmed. Anal edema caused by mixed hemorrhoid in clinical and pain in patients with symptoms,is an pressures for doctors to solve.The purpose of this study is repeating anal edema model in rats by croton oil, researching and discussing its anti-inflammation, detumescence and analgesic effects and mechanism on the anus edema model. And from the two aspects of conservative treatment and surgical treatment of clinical observation, to analyze that GTX can improve the situation of anal edema caused by inflammatory mixed hemorrhoid symptoms, to discuss inhibition of inflammatory cytokines and the mechanism of action of inflammatory mediators.
2Methods
This study is divided into three parts.The first part is the literature research. First concluding TCM etiology and pathogenesis of anal edema caused by mixed hemorrhoid, Western medicine theories of hemorrhoids, microscopic understanding of edema and vascular endothelial function, summarizing the current research progress of non-surgical therapy of traditional Chinese and western medicine treatment of inflammatory mixed hemorrhoid, these will help us find the point of animal experiment and clinical observation research on GTX foaming agent and the related factors of the meaning. Then including a meta analysis of external treatment of traditional Chinese medicine to inflammatory hemorrhoids. The last part of the literature research by summarizing the tutor professor Zhao Baoming's clinical experiences, we can remember the review of GTX in the early period and my learning experiences. The second part is animal experiment parts. It mainly includes the experiment of building SD rats anal edema model by croton oil, the second is observing how GTX can treat the pain of the model, the third one is using enzyme-linked immune sorbent assay to measure TNF-a and IL-6,the last is using immunohisto-chemistry to measure iNOS. From these four aspects to prove GTX foam aerosol has the effect of analgesia, anti-inflammatory and detumescence to anal edema of rat model of inflammatory pain.The third part is the part of clinical observation. The first is an randomized controlled single-blind trial, to observe GTX foam aerosol using as a conservative treatment to outpatients who has the symptoms of anal edema by mixed hemorrhoids. and to record the symptoms integral before and after medication. The second clinical observation is using GTX foam aerosol to anal edema patients caused by mixed hemorrhoid before surgery, then measuring the content of iNOS,IL-6and TNF-a in postoperative hemorrhoid tissues and comparing them.
3Results
3.1the results of animal experiments
3.1.1anal swelling model of SD rats caused by croton oil
After the morphological changes and pathological section from SD rats which is anal swelling caused by croton oil, it can infer that the change of the model is in accordance with acute inflammatory change and also similar to acute onset hemorrhoids inflammatory change. The biopsy of GTX group is significantly changed, especially for mucosal epithelium and gland of the proximal anus. The lack of epithelium and glands just after molding can gradually complete after using GTX. The edema of submucosa, congestion of blood vessel. the expansion degree is also significantly reduce which is compared with model group.
3.1.2analgesic effect of GTX foam aerosol to anal edema of rat model
Mechanical withdrawal threshold and thermal withdrawal latency are comparable for each group before six hours.
Mechanical withdrawal threshold comparison of each group six hours after building the model,P<0.05, the difference is statistically significant. It suggests there are differences between groups. Positive control group, the large and the middle dose of GTX group are changed after using medication, P<0.05, their significant difference is statistically significant. Six hours after giving medicine. MWT of each group are normal distribution, and variance. Model group, negative control group, GTX foam aerosol high-dose group and small dose group's MWT value compared with the blank group, P<0.05, the difference is statistically significant. Positive control group and GTX middle-dose groups compared, P>0.05, there was no statistically significant difference.
Thermal withdrawal latency comparison of each group six hours before building the model,P>0.05, no statistical significance, it prompts that each thermal pain threshold comparable. Thermal withdrawal latency of positive control group, GTX foam aerosol large dose group and middle dose group are changed significantly after using medicine,P<0.05, significant difference is statistically significant.Six hours after the treatment,the blank group and the GTX foam aerosol high-dose group compared with positive control group,P>0.05, there was no statistically significant difference.
3.1.3the content of TNF-a and IL-6by using Elisa method
With Elisa method, TNF-a and IL-6content of the normal group and model group serum have obvious differences, P<0.05. It is statistically significant. Anal edema of SD rats model by croton oil conforms to the inflammatory change.GTX has no obvious difference with indomethacin suppository group, P>0.05.It shows that indomethacin suppository effect is more obvious than GTX. The three groups of GTX compare with each other have no significant differences, P>0.05, temporarily it can't explain each dose limit effect relationship.
3.1.4the content of iNOS by using immunohisto chemical method
Using immunohistochemical method to observe the rats'crissum tissues, the expression of iNOS of each does GTX foam aerosol group are less than model group, more than control group. Especially the small dosage group increases obviously. Each dose GTX group comparing with model group and the blank group, there is no statistical difference by the study optical density value of immunohistochemical. GTX foam aerosol cannot infer it has no inhibition of iNOS.
3.2the results of clinical observations
3.2.1the clinic symptoms integral changes
To observe the clinic symptoms integral changes:the sex, age, course, mixed hemorrhoid stages of three groups are comparable, so are the pain, bloody, bearing-down pain, the prolapsed, the erosion of hemorrhoids mucosa and swelling of the situation before using treatments. GTX and indomethacin groups'scores of VAS decreased obviously after seven days' therapy. The bloody symptom is the most obvious before using GTX foam aerosol, then it becomes the lowest one of the three groups. After using GTX for seven days,bearing-down pain decreased obviously than others. And GTX group for repairing hemorrhoids mucosal is superior to other two groups, the PUJI hemorrhoids suppository is better than indomethacin one.GTX is slower than indomethacin bolt on the size of the haemorrhoids detumescence effect, and is consistent with the changes of haemorrhoids swelling area.There is no statistically significant difference between these two groups.
The overall efficient of GTX group (98.5%) is obviously higher than indomethacin suppository group (96.8%), and PUJI group (90.1%).
3.2.2the expression of IL-6, TNF-a and iNOSby using immunohistochemical method
Using immunohistochemical method to observe the expression of IL-6, TNF-a and iNOS from edema hemorrhoid tissues. The blank group are more positive expressed in three sets of pictures, GTX foam aerosol express less, the least is indomethacin suppository group.The immunohistochemical study optical density value comparison:GTX foam aerosol group compare with indomethacin suppository group for IL-6, P>0.05, for TNF-a and iNOS, P<0.05.Comparing with the blank group forIL-6and iNOS, P>0.05,for TNF-a,P<0.05.
4Conclusion
GuangTongXiao foam aerosol has the exact anti-inflammation, detumescence and analgesic effect in treating anal swelling SD rats model caused by croton oil.It also can stop the pain and reduce the swelling, repair the haemorrhoids mucosa, lift the location of haemorrhoids position of anal edema caused by mixed hemorrhoid,such as anal edema, pain, bloody and other symptoms. And the effect is better than indomethacin suppository group and PuJi group. We can conclude that Chinese traditional medicine in improving the bloody symptom and repairing the haemorrhoids mucosa is obviously better than indomethacin suppository.
The mechanism of anti-inflammatory swelling and stoping the pain may be related to reducing the expression of TNF-a and IL-6for GuangTongXiao foam aerosol,Inhibiting the activation of iNOS,reducing the release of NO,so as to achieving the purpose of anti-inflammation, detumescence and analgesia. And the concentration-response relationships of each does of GTX deserve to be further discussed.
广痛消泡沫气雾剂是导师赵宝明教授开发研制,前期研究已表明该剂型在治疗混合痔、肛裂等肛肠疾病,既有中医药特色,又有外治优势,其剂型在国外也被广泛应用,该药止痛、解痉作用机理已得到证实。混合痔引起的肛门水肿在临床多见,患者痛苦症状明显,急待医者解决。本研究目的通过利用巴豆油致大鼠肛门水肿模型,研究并探讨广痛消泡沫气雾剂对此模型的抗炎、消肿、止痛作用及机制,并从临床观察门诊治疗和术后病理组织两方面,分析探讨广痛消泡沫剂对炎性痔临床症状的治疗作用,以及抑制炎性细胞因子和炎症反应的作用机制。
2方法
本研究分为三部分。第一部分为文献研究,首先通过归纳混合痔引起肛门水肿的中医病因病机,从宏观上探讨痔的发病学说以及水肿与血管内皮功能的微观认识,总结目前中西医非手术疗法治疗炎性痔的研究进展,从中找到广痛消泡沫剂消肿作用的研究切入点及相关因子的意义。其次以中药外治法治疗炎性痔为主题,进行Meta分析研究,探讨该方法的有效性及安全性。最后通过总结导师赵宝明教授临床经验,回顾该剂型的前期以及汇报本人跟师学习的体会。第二部分为动物实验部分,主要包括实验一巴豆油致SD大鼠肛门水肿模型的建立,实验二主要观察广痛消泡沫气雾剂对大鼠肛门水肿模型的止痛作用,实验三采用酶联免疫吸附法测定TNF-a和IL-6,实验四免疫组化法测iNOS,从以上四方面来证实广痛消泡沫气雾剂对大鼠肛门水肿有抗炎、止痛、消肿的作用。第三部分为临床观察部分,首先通过随机对照、单盲观察广痛消泡沫气雾剂治疗炎性痔门诊患者疗效,用药前后症状积分的改善情况,其次对炎性痔患者术前给予广痛消泡沫气雾剂治疗,术后用免疫组化法测定痔组织内iNOS、TNF-α、IL-6含量的变化等,客观反映该剂型的抗炎作用机制。
3结果
3.1动物实验结果
3.1.1巴豆油致大鼠肛门水肿模型
通过巴豆油致SD大鼠肛门肿胀的形态改变和病理组织切片,提示SD大鼠肛门肿胀模型符合急性炎症改变,与痔疮急性发作时炎性改变相似。广痛消泡沫气雾剂组的组织切片中肛门近端黏膜上皮及腺体从造模后缺失到给药后逐渐修复完整,粘膜下层水肿、血管充血、扩张程度也较模型组明显减轻。
3.1.2广痛消泡沫气雾剂对大鼠肛门水肿模型的止痛作用
各组造模前6h机械痛阈值和热痛阈值具有可比性。
造模后6h各组间机械痛阈值比较P<0.05,差异具有统计学意义,提示各组间有差异。阳性对照组、广痛消泡沫气雾剂大剂量组、中剂量组给药前后机械性收缩反射阈值变化明显,且用药前后比较,P<0.05,差异显著并具有统计学意义。末次给药6h后MWT值均正态分布,且方差齐。末次给药后6h模型组、阴性对照组、广痛消泡沫气雾剂大剂量组和小剂量组与空白组MWT值比较,P<0.05,差异具有统计学意义；阳性性对照组与广痛消中剂量组比较,P>0.05,差异无统计学意义。
造模前6h各组间TWL值比较P>0.05,无统计学意义,提示各组热痛阈值具有可比性。阳性对照组、广痛消泡沫气雾剂大剂量组和中剂量组给药前后热痛阈值变化明显,P<0.05,差异显著并具有统计学意义。末次给药后6h,空白组、广痛消大剂量组与阳性对照组比较,P>0.05,差异无统计学意义。
3.1.3酶联免疫吸附法测定TNF-a和IL-6含量
通过Elisa法测定动物肛周组织及直肠下段,正常组与模型组中’TNF-a和IL-6含量有明显差异,P<0.05,具有统计学意义,说明巴豆油致SD大鼠肛门水肿模型符合炎症改变。广痛消泡沫气雾剂各组与消炎痛栓组的TNF-a和IL-6含量无明显差异,P>0.05,差异无统计学意义；广痛消泡沫气雾剂各组之间两种因子的含量两两比较无明显差异,P>0.05,暂不能说明各个剂量无量效关系。
3.1.4免疫组化法iNOS的表达
通过免疫组化法观察大鼠肛周组织及直肠下段,广痛消泡沫气雾剂各剂量组iNOS的表达均少于模型组,较阳性对照组增多,以小剂量组增多明显。测定免疫组化染色光密度值,广痛消泡沫气雾剂各剂量组与模型组、空白组无统计学差异,P>0.05,暂不能说明广痛消泡沫气雾剂对iNOS的表达无抑制作用。
3.2临床观察结果
3.2.1门诊患者症状积分改变
三组患者用药前性别、年龄、病程、混合痔分期,以及用药前疼痛、便血、坠痛、脱垂、痔黏膜糜烂情况、痔肿胀大小情况均具有可比性。用药治疗7天后,广痛消组和消炎痛组疼痛VAS积分明显降低；广痛消泡沫气雾剂组用药前便血症状积分最高,用药后便血积分最低；广痛消组坠痛积分下降幅度明显且第7天时积分最低；广痛消组对痔核黏膜的修复作用明显优于其它两组,普济痔疮栓对痔核表面的改善作用优于消炎痛栓组；广痛消泡沫气雾剂对痔核大小的消肿作用起效时间较消炎痛栓组慢,对痔核肿胀面积的改变与消炎痛栓组结果相一致,差异无统计学意义。三组总体有效率广痛消组(98.5%)明显高于消炎痛栓组(96.8%)和普济痔疮栓组(90.1%)。
3.2.2免疫组化法测定IL-6、TNF-a、iNOS的表达
利用免疫组化法观察水肿痔组织内的IL-6、TNF-a、iNOS的表达：三组图片中阳性表达最多的为空白组,表达较少的为广痛消泡沫气雾剂组,最少的是消炎痛栓组。广痛消泡沫气雾剂组与消炎痛栓组IL-6的免疫组化染色光密度值比较,P>0.05, TNF-a和iNOS的免疫组化染色光密度值比较P<0.05；与空白组IL-6、iNOS的免疫组化染色光密度值比较,P>0.05, TNF-a的OD值比较P<0.05。
4结论
广痛消泡沫气雾剂对于治疗巴豆油致SD大鼠肛门水肿有确切的抗炎、消肿、止痛的作用。临床观察广痛泡沫气雾剂对炎性痔引起的疼痛、便血等症状有明显的止痛、消肿、修复痔核黏膜、提升痔核位置的作用,总体效果明显优于消炎痛栓组和普济痔疮栓组。而且中药组在改善便血和修复痔核黏膜方面明显优于消炎痛栓组。
广痛消泡沫气雾剂抗炎消肿、止痛的作用机制主要是该药能够降低TNF-a和IL-6的表达,抑制了iNOS的激活,减少NO的释放,从而达到抗炎、消肿、止痛的目的,其量效关系值得进一步探讨。
GuangTongXiao Foam Aerosol(GTX) is invented by professor Zhao Baoming. Previous studies have shown the dosage form in the treatment of mixed hemorrhoids, anal fissure and other anorectal diseases has both features of traditional Chinese medicine and external treatment advantage. The dosage form has been widely used in foreign countries. GTX's mechanism of relieving pain and spasmolysis has been confirmed. Anal edema caused by mixed hemorrhoid in clinical and pain in patients with symptoms,is an pressures for doctors to solve.The purpose of this study is repeating anal edema model in rats by croton oil, researching and discussing its anti-inflammation, detumescence and analgesic effects and mechanism on the anus edema model. And from the two aspects of conservative treatment and surgical treatment of clinical observation, to analyze that GTX can improve the situation of anal edema caused by inflammatory mixed hemorrhoid symptoms, to discuss inhibition of inflammatory cytokines and the mechanism of action of inflammatory mediators.
2Methods
This study is divided into three parts.The first part is the literature research. First concluding TCM etiology and pathogenesis of anal edema caused by mixed hemorrhoid, Western medicine theories of hemorrhoids, microscopic understanding of edema and vascular endothelial function, summarizing the current research progress of non-surgical therapy of traditional Chinese and western medicine treatment of inflammatory mixed hemorrhoid, these will help us find the point of animal experiment and clinical observation research on GTX foaming agent and the related factors of the meaning. Then including a meta analysis of external treatment of traditional Chinese medicine to inflammatory hemorrhoids. The last part of the literature research by summarizing the tutor professor Zhao Baoming's clinical experiences, we can remember the review of GTX in the early period and my learning experiences. The second part is animal experiment parts. It mainly includes the experiment of building SD rats anal edema model by croton oil, the second is observing how GTX can treat the pain of the model, the third one is using enzyme-linked immune sorbent assay to measure TNF-a and IL-6,the last is using immunohisto-chemistry to measure iNOS. From these four aspects to prove GTX foam aerosol has the effect of analgesia, anti-inflammatory and detumescence to anal edema of rat model of inflammatory pain.The third part is the part of clinical observation. The first is an randomized controlled single-blind trial, to observe GTX foam aerosol using as a conservative treatment to outpatients who has the symptoms of anal edema by mixed hemorrhoids. and to record the symptoms integral before and after medication. The second clinical observation is using GTX foam aerosol to anal edema patients caused by mixed hemorrhoid before surgery, then measuring the content of iNOS,IL-6and TNF-a in postoperative hemorrhoid tissues and comparing them.
3Results
3.1the results of animal experiments
3.1.1anal swelling model of SD rats caused by croton oil
After the morphological changes and pathological section from SD rats which is anal swelling caused by croton oil, it can infer that the change of the model is in accordance with acute inflammatory change and also similar to acute onset hemorrhoids inflammatory change. The biopsy of GTX group is significantly changed, especially for mucosal epithelium and gland of the proximal anus. The lack of epithelium and glands just after molding can gradually complete after using GTX. The edema of submucosa, congestion of blood vessel. the expansion degree is also significantly reduce which is compared with model group.
3.1.2analgesic effect of GTX foam aerosol to anal edema of rat model
Mechanical withdrawal threshold and thermal withdrawal latency are comparable for each group before six hours.
Mechanical withdrawal threshold comparison of each group six hours after building the model,P<0.05, the difference is statistically significant. It suggests there are differences between groups. Positive control group, the large and the middle dose of GTX group are changed after using medication, P<0.05, their significant difference is statistically significant. Six hours after giving medicine. MWT of each group are normal distribution, and variance. Model group, negative control group, GTX foam aerosol high-dose group and small dose group's MWT value compared with the blank group, P<0.05, the difference is statistically significant. Positive control group and GTX middle-dose groups compared, P>0.05, there was no statistically significant difference.
Thermal withdrawal latency comparison of each group six hours before building the model,P>0.05, no statistical significance, it prompts that each thermal pain threshold comparable. Thermal withdrawal latency of positive control group, GTX foam aerosol large dose group and middle dose group are changed significantly after using medicine,P<0.05, significant difference is statistically significant.Six hours after the treatment,the blank group and the GTX foam aerosol high-dose group compared with positive control group,P>0.05, there was no statistically significant difference.
3.1.3the content of TNF-a and IL-6by using Elisa method
With Elisa method, TNF-a and IL-6content of the normal group and model group serum have obvious differences, P<0.05. It is statistically significant. Anal edema of SD rats model by croton oil conforms to the inflammatory change.GTX has no obvious difference with indomethacin suppository group, P>0.05.It shows that indomethacin suppository effect is more obvious than GTX. The three groups of GTX compare with each other have no significant differences, P>0.05, temporarily it can't explain each dose limit effect relationship.
3.1.4the content of iNOS by using immunohisto chemical method
Using immunohistochemical method to observe the rats'crissum tissues, the expression of iNOS of each does GTX foam aerosol group are less than model group, more than control group. Especially the small dosage group increases obviously. Each dose GTX group comparing with model group and the blank group, there is no statistical difference by the study optical density value of immunohistochemical. GTX foam aerosol cannot infer it has no inhibition of iNOS.
3.2the results of clinical observations
3.2.1the clinic symptoms integral changes
To observe the clinic symptoms integral changes:the sex, age, course, mixed hemorrhoid stages of three groups are comparable, so are the pain, bloody, bearing-down pain, the prolapsed, the erosion of hemorrhoids mucosa and swelling of the situation before using treatments. GTX and indomethacin groups'scores of VAS decreased obviously after seven days' therapy. The bloody symptom is the most obvious before using GTX foam aerosol, then it becomes the lowest one of the three groups. After using GTX for seven days,bearing-down pain decreased obviously than others. And GTX group for repairing hemorrhoids mucosal is superior to other two groups, the PUJI hemorrhoids suppository is better than indomethacin one.GTX is slower than indomethacin bolt on the size of the haemorrhoids detumescence effect, and is consistent with the changes of haemorrhoids swelling area.There is no statistically significant difference between these two groups.
The overall efficient of GTX group (98.5%) is obviously higher than indomethacin suppository group (96.8%), and PUJI group (90.1%).
3.2.2the expression of IL-6, TNF-a and iNOSby using immunohistochemical method
Using immunohistochemical method to observe the expression of IL-6, TNF-a and iNOS from edema hemorrhoid tissues. The blank group are more positive expressed in three sets of pictures, GTX foam aerosol express less, the least is indomethacin suppository group.The immunohistochemical study optical density value comparison:GTX foam aerosol group compare with indomethacin suppository group for IL-6, P>0.05, for TNF-a and iNOS, P<0.05.Comparing with the blank group forIL-6and iNOS, P>0.05,for TNF-a,P<0.05.
4Conclusion
GuangTongXiao foam aerosol has the exact anti-inflammation, detumescence and analgesic effect in treating anal swelling SD rats model caused by croton oil.It also can stop the pain and reduce the swelling, repair the haemorrhoids mucosa, lift the location of haemorrhoids position of anal edema caused by mixed hemorrhoid,such as anal edema, pain, bloody and other symptoms. And the effect is better than indomethacin suppository group and PuJi group. We can conclude that Chinese traditional medicine in improving the bloody symptom and repairing the haemorrhoids mucosa is obviously better than indomethacin suppository.
The mechanism of anti-inflammatory swelling and stoping the pain may be related to reducing the expression of TNF-a and IL-6for GuangTongXiao foam aerosol,Inhibiting the activation of iNOS,reducing the release of NO,so as to achieving the purpose of anti-inflammation, detumescence and analgesia. And the concentration-response relationships of each does of GTX deserve to be further discussed.
引文
[1]吴昆.《黄帝内经·素问》[M].北京：学苑出版社,2001,14.
[2]南京中医学院校释.《诸病源候论校释》(下册)[M]一北京：北京人民卫生出版社,1982,954.
[3]吴剑箫,吴春晓,王延峰.痔疮的瘀毒病因病机探究[J].河北中医,2012,34(5)：755-756.
[4]朱震亨.《丹溪心法》[M].北京,北京市中国书店出版,年代卷2：140.
[5]战晓农,余成栋.浅谈古代医家对痔疮病因病机的认识[J].江苏中医药,2006,27(9)：16-17.
[6]申斗垣.《外科启玄》[M].北京,人民卫生出版社,1956,卷7：50.
[7]陈实功.《外科正宗》[M].北京,民卫生出版社,1973,169.
[8]吴谦等.《医宗金鉴》[M].北京,人民卫生出版社,1996,卷69：300.
[9]陈梦雷.《古今图书集成医部全录》[M].北京,人民卫生出版社,1985：227.
[10]赵宝明.新世纪中国肛肠名老中医学术传承与发展战略思考[A].田振国,韩宝.中国肛肠病研究心得集[C].北京：中国古籍出版社,2011：52-532.
[11]王业皇.丁泽明肛肠病治法特点初探[J].南京中医学院学报,1993,9(4)：23-24.
[12]史仁杰.朱秉宜痔科学术经验[J].中医文献杂志,1998,3：38-39.
[13]魏照洲.从瘀论治痔疮[J].四川中医,2006,24(11)：76-77.
[14]皇甫少华,丁曙晴,丁义江.痔中医辨证分型的文献依据[J].吉林中医药,2011,31(12)：1195-1197.
[15]中华中医药学会.中医肛肠科常见病诊疗指南[S].北京：中国中医药出版社,2012：1-4.
[16]韩晓光,包庆慧.痔血的研究进展[J].结直肠肛门外科,2006,12(5)：322-324.
[17]Quenu E. Des arteres du rectum et de I'anus chez I'homme et chez lafemme[J].Bul.Soc.Anat,1893,7:703-708.
[18]Parks AG. HemorrhoidsHosp[J].Rep,1995,104(2):135-156.
[19]张东铭.痔的病因与病理生理学的现代概念[J].中国肛肠病杂志,2001,21(11)：39.
[20]Hunt AH.Discussioon on Portal Hypertension[J]. Proc R socMed,1954,47(6):469-475.
[21]Waddell WG, Bouchard AG, Wellington JL, et al. Functional relations of the proximal components of the portal system,a preliminary report[J]. J Surg Res,1972,12(4):281-289.
[22]Thomson WH. The nature of haemorrhoids[J].Br J Surg,1975,62(7):542-552.
[23]Bernstein WC. What are hemorrhoids and what is their relationship to the portal system[J].Dis Colon Rectum,1983,26(12):829-834.
[24]Shafid A. Aconcept of the anatomy of the anal sphincter mechanism and the physiology of defecation[J].Dis Colon Rectum,1987,30(12):970-82.
[25]张东铭,孟庆有,钱雨根,等.肛门部血管分布[J].中国肛肠病杂志,1986,6(2)：3.
[26]Gass OC,Adams J.Hemorrhoids; etiology and pathology[J].Am J Surg.1950,79:40-43.
[27]Alexander-WilliamsJ,Crapp AR. Conservative management of haemorrhoids[J].Clin Gastroenterol.1975,4(3):595-618.
[28]Stelzner F, Staubesand J,Machleidt H.The corpus cavernosum recti basis of internal hemorrhoids [J]. Langenbecks Arch Klin Chir Ver Dtsch Z ChirJ 962.299:302-312.
[29]Parnand E,Guntz M, Bernard A, et al. Normal macroscopic and microscopic anatomy of the hemorrhoidal vascular system [J]. Arch Fr Mal App Dig,1976,65(7):501-514.
[30]Elsenhammer S.The evaluation of the interal anal Sphinclerolomy Operation of the interal anal sphinclerotomy operation with special reference to anal fissure[J].Surg Gyn Obst,1959,109:583-590.
[31]Hancock BD,Smith K. The internal sphincter and Lord's procedureforhaemorrhoids[J].BrJ Surg,1975,62(10):833-836.
[32]Schweiger M. Method for determining individual contributions of voluntary and involuntary anal sphincters to resting tone[J]. Dis Colon Rectum.1979,22(6):415-416.
[33]Duthie HL, Watts TM. Contribution of the externalanalsphinctertothe pressurezoneintheanal cana[J]. Gut,1965.6:64-68.
[34]Parks AG,Swash M.Ulrich H. Sphincter enervation in anorectal incontinense and rectal proplapse[J].Gut,1977,18(8):656-665.
[35]AlperD,Ram E,Stein GY,et al.Resting anal pressure following hemorrhoidectomyand lateral sphincterotomy[J]. DisColonRectum,2005,48(11):2080-2084.
[36]Chanhan A,Thomas S, Bishnoi PK.et al. Randomizedcontrolled trial toassess the role of raised analpressures in the pathogenesis ofsymptomatic early hemorrhoids[J].Dig Surg,2007,24(1):28-32.
[37]张东铭.痔与盆底动力学关系[J].大肠肛门病外科杂志,2000,6(4)：49-54.
[38]Duthy HL,Gairns FW. Senosory nerve ending and sensation in the anal region of man[J]. Br J Surg,1960,47:585-595.
[30]RoeAM,BartoloDC,VeiiacottKD,et al.Submucosal versus ligation excision haemorrhoidectomy:a comparison ofanal sensation,anal sphinctermanometry and postoperative pain and function[J]. Br J Surg,1987,74(10):948-951.
[40]MillerR,Bartolo DC,Roe A,et al.Anal sensation and the continencemechanism[J].DisColon Rectum,1988,31(6):433-438.
[41]Sleisinger MH,Fordtran JS.Gastrointestinal and liverdisease.Path physiology, diagnosis, management[M]. W.B.Saunders Company.2010:1796.
[42]Burkitt DP. Varicose veins,deep vein thrombosis and hemorrhoids epidemiology and suggested etiology[J].Br Med J,1972,2(2813):556-561.
[43]Read NW,Sun WM. Hemorrhoids constipation and hypertensive analcushions[J].Lancet, 1989,1(8636):610.
[44]JahansonJF, SonnenbergA. Theprevalence of hemorrhoids and chronicconstipation. An epidemiologic study[J]. Gastroenterology,1990,98(2):380-386.
[45]张东铭.痔与便秘[J].中华全科医师杂志,2005,4(7)：403-405.
[46]DelcoF,SormenbergA. Association between hemorrhoids and otherdiagnoses[J].DisColon Rectum,1998,41(12):1534-1542.
[47]张东铭.药物治疗痔病的理论基础[A].田振国,韩宝.中国肛肠病研究心得集[C].北京：中国古籍出版社,2011：83-87.
[48]熊一力,将学俊,刘启功,等.VEGF基因对缺氧诱导的内皮细胞凋亡和坏死的影响[J].上海免疫学杂志,1999,19(6)：358-360.
[49]Mason RB,Pluta RM,Walbridge S,et al. Production of reactive oxygen species after reperfusion in vitro and in vivo:Protective effect of nitric oxide [J]. J Neurosurg,2000,93(1):99-107.
[50]高治平,李波平,黄红林,等.缺氧/复氧损伤对血管内皮细胞NO生成和脂质过氧化物的影响[J].南华大学学报·医学版,2003,31(3)：265-266,285.
[51]陈高阳,刘延庆.一氧化氮与疼痛的研究进展[J].国外医学·麻醉学与复苏分册.2004,25(3)：177-179.
[52]袁伟,张学渊.剪切力对血管内皮细胞的生物学影响[J].重庆医学,2003,32(11)：1490-1492.
[53]Adel MM,Izumo S. Mechanism of endothelial cell shapechange and cytoskeletal remodeling in response to fluid shearstress[J].J Cell Seience,1996,109(Pt4):713-726.
[54]Waters CM.Flow-induced modulation of the permeability of endothelial cells alltured on microcarrier beads[J].J Cellul Physiol,1996,168(2):403-411.
[55]王贵学,罗向东,蔡绍皙,等.内皮细胞代谢剪切作用时间的相关性[J].生物物理学报,1999,15(2)：407.
[56]陈友琴,陈槐卿.不同型式活体切应力对血管内皮细胞生理生化的影响[J].国外医学生物医药工程分册,2000,23(4)：233.
[57]陈玲,张清华,蒋知新.炎症因子对人脐静脉内皮细胞表达血管内皮生长因子及妊娠相关血浆蛋白-A的影响[J].广东医学,2009,30(2)：194-195.
[58]潘志国,耿焱,张剑明.热刺激对体外培养的血管内皮细胞损伤及IL-6、TNF-α释放的影响[J].山东医药,2012,52(3)：32-34.
[59]陈清华,袁肇凯.中医药与血管新生研究进展[J].中国中医药信息杂志,2007,14(8)：89-91.
[60]韩炜,王振军,赵博,等.痔组织弹性纤维退变和血管生成的机制及其意义[J].中华胃肠外科杂志,2005,8(1)：56-59.
[61]徐跃军,张端莲,吴惠芬,等.痔疮组织中血管内皮生长因子的表达及意义[J].数理医药学杂志,2007,20(4)：461-462.
[62]刘长宝,鲍银童,金定国.金氏痔疮膏对大鼠肛管静脉从血管内皮细胞生长因子表达的影响[J].中国中西医结合外科杂志,2007,13(3)：267-269.
[63]牛治君,牛明星.大黄牡丹汤加味治疗嵌顿性内痔30例报告[J].中国中医急症,1994, 3(5)：209-210.
[64]郭永红.麻杏石甘汤加味治疗急性嵌顿痔36例[J].新中医,2002,34(12)：52.
[65]尚锦秀,吴汉泉,李华春,等.急性嵌顿痔的中西医结合治疗[J].中国中西医结合外科杂志,2008,14(2)：112-113.
[66]汤成泳,李娟,何海霞,等.五味痔疮胶囊的抗炎作用研究[J].重庆医学,2011,40(24)：2432-2434.
[67]张庚扬,杜钰生.化痔栓治疗痔疮的临床药理研究[J].天津中医药,2003,20(2)：17-19.
[68]张媛,赵宝明.近十年来国内肛肠病中药栓剂研究概况[J].辽宁中医药大学学报,2014,16(2)：271-271.
[69]韦耀力,胡俊杰.苍耳子熏洗治疗炎性痔102例临床观察[J].中医临床研究,2011,3(3)：29-30.
[70]郭纯艳,魏洪亮.痔洗药Ⅰ号治疗炎性外痔80例临床观察[J].中国肛肠病杂志,2009,29(10)：28-29.
[71]周志成.清热消肿膏外敷治疗炎性痔750例[J].中医药学报,1997,4：6.
[72]李洪杰,孙锋,赵文韬.龙珠软膏外敷治疗炎性外痔42例[J].医药导报,2007,26(10)：1169.
[73]徐红,黄卫国,郭淳.麝香痔疮栓和膏合用保守治疗炎性混合痔的临床研究[J].职业卫生与病伤,2010,25(3)：164-165.
[74]裴穗东.针刺二白穴治疗痔痛49例[J].四川中医,2003,21(9)：78.
[75]赵麦焕,杨淑娥.针刺治疗Ⅲ期环状混合痔[J].中华实用中西医杂志,2005,18(8)：1152-1153.
[76]曹朕笃,杨彦平,李亚东.针刺治疗痔疮19例[J].湖南中医杂志,2004,20(4)：40-41.
[77]陈少明,修治平.挑痔疗法治疗肛肠病[J].中国肛肠病杂志,1995,15(5)：43.
[78]Ramelet AA. Pharmacologic aspects of a plebotropic drug in CVI-associated edema[J]. Angiology,2000,51(1):19-23.
[79]Labrid C. Pharmacologic properties of Daflon 500mg[J].Angiology,1994,45(6Pt2): 524-530.
[80]周璐.地奥司明[J].医药导报,2007,26(10)：1235-1236.
[81]Godeberge P.Daflon 500mg in the treatment of hemorrhoidal disease:a demonstrated efficacy in comparison with placebo[J]. Angiology,1994,45 (6 Pt 2):574-578.
[82]王世文,张颖.地奥司明片治疗痔疮急性发作1100例[J].医药导报,2009,28(1)：76-77.
[83]邓斌,徐飞,邱刚林.地奥司明片用于急性嵌顿痔围手术期46例[J].医药导报,2012,31(5)：631-632.
[84]周学健,袁忠,张兵,等.地奥司明联合硫酸镁坐浴治疗炎性外痔50例[J].江苏医药,2012,38(16)：1971-1971.
[85]周天球.迈之灵治疗内痔83例临床观察[J].中医杂志,2004,48：183.
[86]薛建国,王宇,谷俊朝.喜疗妥、迈之灵治疗急性嵌顿痔疗效观察[J].结直肠肛门外科,2008,14(6)：403-404.
[87]张碧群.太宁栓外用配合迈之灵治疗痔疮78例[J].陕西中医,2010,31(9)：1176.
[88]傅传刚,杨巍,孙建华,等.草木犀流浸液片剂治疗痔的疗效研究[J].中华胃肠外科杂志,2004,7(4)：270-272.
[89]张丽娜,史惠卿,陆国庆.静可福[J].中国新药杂志,2004,13(5)：471-472.
[90]杨新庆,陈朝文.复方银杏叶萃取物胶囊用于痔术后的临床研究[J].大肠肛门病外科杂志,2004,10(1)：44-46.
[91]阮向红.硫酸镁甘油湿敷在嵌顿痔水肿防治中的应用[J].结直肠肛门外科,2008,14(3)：163-165.
[92]陈天杰.高渗葡萄糖治疗痔疮习阵月中临床观察86例[A].符中柱.贵州省中西医结合学会肛肠学会第五届学术交流会暨新技术新进展学习班论文汇编[C].贵州：2012：69.
[93]俞静,花宝,朴炳奎.延胡索乙素对放射所致血管内皮细胞损伤的保护作用[J].中华肿瘤防治杂志,2011,18(8)：584-585.
[94]傅保娣,刘玉娥,张岫美,等.芍药苷对缺氧损伤内皮细胞产生NO、eNOS和细胞粘附分子的影响[J].药物分析杂志,2007,27(4)：555-556.
[95]刘海.痔浴液治疗炎性外痔120例临床观察[J].时珍国医国药.2005,16(5)：408-409.
[96]林锡芬,赖庆勇,钟希文.痔舒息洗剂治疗炎性痔100例[J].江西中医药,2006,37(6)：33-34.
[97]王伟军,刘行稳.自拟外洗方治疗炎性外痔的临床观察[J].湖北中医杂志,2006,28(5)：42.
[98]杜文敏,周小燕,郑雄彦.中药熏洗坐浴治疗炎性外痔的疗效观察[J].当代护士(学术版),2007,54(5)：81-82.
[99]李国栋.痔炎宁熏洗剂治疗痔疮85例[J].中医研究,2008,11(9)：32-34.
[100]王艳辉.自拟中药汤剂外洗治疗炎性痔疗效观察[J].中国现代药物应用,2009,3(11)：123.
[101]曹宇,葛昌甫.痔瘘袋泡洗剂治疗炎性痔的临床观察[J].吉林医学,2010,31(5)：615-616.
[102]李浩.中药汤剂外洗保守疗法治疗炎性痔疗效分析[J].中国现代药物应用,2010,4(15)：15-16.
[103]田社清,刘行稳.消肿祛痔汤治疗炎性痔临床观察[J].中西医结合研究,2010,2(1)：15-17.
[104]赵壁.外洗法治疗炎性痔疮80例临床观察[J].健康必读(下半月),2011(10)：250.
[105]刘世茹,陈敏,郝秀艳,等.中药苦参汤加减熏洗治疗炎性外痔的临床观察[J].西部医学,2011,23(9)：1745-1746.
[106]李晓华,张重阳,邢志勇,等.自拟消肿止痛汤熏洗配合金黄膏外敷治疗炎性外痔70例[J].中国中医急症,2011,20(1)：149.
[107]李洋,梁劲军.芒硝外洗方治疗炎性外痔60例[J].中医研究,2011,24(3)：12-14.
[108]刘忠.中药痔瘘洗剂坐浴治疗炎性外痔48例[J].内蒙古中医药,2013,32(20)：16.
[109]王爱华.中药外洗治疗炎性痔疮45例[J].河南中医,2013,33(6)：928-929.
[110]刘成伟,潘素滢.痔宁熏洗冲剂治疗炎性痔106例临床观察[J].新中医,2003,35(4)：25-26.
[111]赵宝明.正确掌握经典痔切除手术[A].田振国、韩宝.中国肛肠病研究心得集[C].中国古籍出版社：中华中医药学会,2011,95-96.
[112]赵宝明,张书信.固脱法与PPH术联合应用的临床研究[A].刘学彦、车名海、王华.中华中医药学会第十二次大肠肛门病学术会议论文汇编[C].中国吉林：中华中医药学会,2006,488-490.
[113]赵宝明,王艳逊,廖培辰,等.中医外科固脱法治疗脱肛溯源及临床应用[J].北京中医,2007,26(7);402-404.
[114]廖培辰.中医外治固脱法治疗脱肛(直肠脱垂)疗效观察[D].北京：北京中医药大学,2005.
[115]彭俊付.中医外治注射固脱法治疗直肠前突疗效观察[D].北京：北京中医药大学,2007.
[116]王锐.中医外治固脱法与PPH术联合应用治疗直肠粘膜内脱垂临床观察[D].北京：北京中医药大学,2007.
[117]易其星.中医固脱法联合松解术治疗PRS+IRP型便秘的临床观察[D].北京：北京中医药大学,2010.
[118]张书信,赵宝明.综合固脱法在盆底疾病治疗中的应用[A].田振国、韩宝.中国肛肠病研究心得集[C].中国古籍出版社：中华中医药学会,2011,297-298.
[119]赵宝明.中医外治固脱法硬化阻断防治肿瘤[A].田振国、韩宝.2012医学前沿——中华中医药学会肛肠分会第十四次全国肛肠学术交流大会论文精选[C].中国古籍出版社：中华中医药学会,2012,334-338.
[120]赵宝明,史兆岐,景建中.广痛消泡沫气雾剂对肛门直肠疾病止痛作用的临床研究[J].中医杂志,1998,39(7)：412.
[121]吴振宇,吴广均,赵宝明.广痛消泡沫气雾剂的止痛解痉作用[J].中国中药杂志,2001,26(8)：559-561.
[122]酒淑玲.广痛消泡沫气雾剂促进混合痔术后创面愈合的临床研究[D].北京.北京中医药大学,2011.
[123]彭俊付.广痛消泡沫气雾剂经直肠粘膜渗透率试验研究及其止痛与安全性临床观察[D].北京.北京中医药大学,2011.
[214]赵宝明,张志谦,张书信等.广痛消泡沫气雾剂止血抗炎作用实验研究[J].中华中医药学刊,2011,29(10)：2164-2165.
[125]葛小栋.广痛消泡沫气雾剂治疗混合痔术后水肿的临床研究[D].北京.北京中医药大学,2012.
[126]张志谦,赵宝明,张书信等.广痛消泡沫气雾剂止痛促愈合的实验研究[J].中国中医药信息杂志,2012,19(3)：33-35.
[127]张志谦.广痛消泡沫气雾剂治疗混合慢性肛裂的疗效观察和机制研究[D].北京.北京中医药大学,2012.
[128]陈浩漩.广痛消泡沫气雾剂治疗内痔便血脱垂及痨核黏膜修复的临床研究[D].北京.北京中医药大学,2013.
[129]王锐,朱莉,邓志灏,等.广痛消泡沫气雾剂在人体血浆中的药代动力学研究[J].中国实验方剂学杂志,2013,19(19)：182-186.
[130]张媛,赵宝明.广痛消泡沫气雾剂对大鼠肛门水肿模型肿瘤坏死因子-a和白细胞介素6的影响[J].2014,22(2)：94-95.
[131]白邈.赵宝明治疗便秘经验[J].中医杂志,2012,53(23)：2047-2048.
[132]谢海洲,杨增良.谢海洲教授治疗脑髓病的经验[J].河南中医,2003,23(12)：16-17.
[1]陈奇.中药药理研究方法学[M].第三版.北京：人民卫生出版社,2011.
[2]国家中医药管理局《中华本草》编委会.中华本草(第4册).上海：上海科学技术出版社,1999：769.
[4]钱伯初,史红,郑晓亮.痔疮动物模型制作方法研究进展[J].中国比较医学杂志,2007,17(2)：119-122.
[5]赵宝明,史兆岐,景建中.广痛消泡沫气雾剂对肛门直肠疾病止痛作用的临床研究[J].中医杂志,1998,39(7)：412.
[6]鲁春梅,张春森,姜立勇,等.延胡索化学成分及药理作用研究进展[J].中国现代药物应用,2011,5(15)：126-127.
[7]李杰萍,梁统,周克元.厚朴酚对大鼠白细胞5-脂氧合酶活性和细胞内钙离子浓度的影响[J].广东医学院学报,2002,20(3)：177-178.
[8]Chaplan SR,Bach FW,Pogrel M,et al.Quantitativeassessment of tactile allodynia in the rat paw[J]. J Neurosci Meth,1994,53(1):55-63.
[9]Hargreaves K,Du bner R,Nolan P,et al. Anew and sensitive method for measuring thermal nociception in cutaneous hyperalgesia[J].Pain,1988,32(1):77-88.
[10]傅开元,Alan R. Light, William Maixner.外周炎症性疼痛刺激诱发中枢神经系统小胶质细胞增殖活化[J].中国神经免疫学和神经病学杂志,2001,8(3)；179-181.
[11]Deleo JA, Colburn RW, Nichols M,et al.Interleukin-6-mediated hyperalgesia allodynia and increased spinal IL-6 expression in a rat mononeuropathy model [J]. J Interferon Cytokine Res,1996,16(9):695-700.
[12]Deleo JA,Colburn RW,Rickman AJ.Cytokine and growth factor immune histochemical spinal profiles in two animal models of mononeuropathy [J].Brain Res,1997,759(1):50-57.
[13]张志谦.广痛消泡沫气雾剂治疗混合慢性肛裂的疗效观察和机制研究[D].北京.北京中医药大学,2012.
[14]王玮,张雪非.爆炸伤创面IL-1、IL-6、TNF-α、CRP的测定[J].中国矫形外科杂志,2007,15(18)：1418-1419.
[15]RaghavendraV,Tanga FY, DeLeo JA.Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS[J]. European Journal of Neuroscience,2004,20(2):467-473.
[16]Cata JP, Weng HR, Dougherty PM. Cyclooxygenase inhibitors and thalidomide ameliorate vincristine-induced hyperalgesia in rats[J]. Cancer Chemother Pharmacol, 2004,54(5):391-397.
[17]Watkins LR,Milligan ED,Maier SF. Glial proinflammatory cytokines mediate exaggerated pain states:implications for clinical pain[J]. Advances in Experimental Medicine & Biology,2003;521:1-21.
[18]赵福涛,丁元晶.白芍总苷在风湿免疫性疾病中的应用进展[J].中国医院药学杂志,2006,26(12)：1546-1548.
[19]郭振军,刘莉,张维璐,等.大黄、当归多糖对巨噬细胞甘露受体作用的研究[-J].细胞与分子免疫学杂志,2008,24(5)： 514-516.
[20]杨周平,武志军.中药黄柏的药理作用和临床应用研究[J].甘肃医药,2010,29(3)：329-331.
[21]Remmele W, Stegner HE.Recomendation for uniform definition of an immunoreactive score(IRS) for immunohistochemical estrogen receptor detection(ER-CIA) in breast cancer tissue[J].Pathology,1987,8(3):138-140.
[22]Elfering SL,Sarkela TM,Giulivi C.Biochemistry of mitochondrial nitric-oxide synthase[J].J Biol Chem,2002,277(41):38086-38097.
[23]PanaroMA,BrandonisioO,AcquafreddaA,etal.EvidencesforiNOS Expression and nitricoxideproductioninthehumanmacrophages[J].CurrDrugTargetsImmuneEndocrMetabolDi sord,2003,3(2):210-221.
[24]Heales SJ,Bolanos JP,Stewart VC,et al. Nitric oxide,mitochondria and neurological disease[J].Biochim BiophysActa,1999,1410(2):215-228.
[25]Tao F,Tao Y X, Mao P,et al.Intact carrageenaninducedthermal hyperalgesia in mice lacking inducible nitric oxidesynthase[J].Neuroscience,2003,120(3):847-854.
[26]金宏波,徐洪伟,刘军.一氧化氮合酶抑制剂L-NNA对福尔马林大鼠脑nNOS.iNOS表达的影响[J].2004,38(5)：407-410.
[27]陈维娜.大鼠甲醛炎性痛时脊髓nNOS和iNOS的表达及胶质细胞抑制剂的影响[D].河北.河北医科大学,2004.
[1]中华医学会外科学分会结直肠肛门外科学组,中华中医药学会肛肠病专业委员会,中国中西医结合学会结直肠肛门病专业委员会.痔临床诊治指南(2006版).中华胃肠外科杂志,2006,9(5)：461-463.
[2]中华中医药学会.中医肛肠科常见病诊疗指南[S]一北京；中国中医药出版社,2012：1-4.
[3]胡金花.肛肠病术后使用消炎痛栓的临床观察及护理[J].上海护理,2002,2(3)：32-33.
[4]张国宝.普济痔疮栓治疗痔疮的临床效果分析[J].中医临床研究,2013,5(6)：61-63.
[5]Richman M D,Shangraw R E.Foams[J].Aerosol Age,1966,11:127.
[6]酒淑玲.广痛消泡沫气雾剂促进混合痔术后创面愈合的临床研究[D].北京.北京中医药大学,2011.
[7]徐逢辰.醋酸氢化可的松泡沫及直肠内给药的临床研究[J].国外医学参考资料,1976,2：86.
[8]徐建军,李鸿进,孟敏.复方醋酸氢化可的松泡沫剂的稳定性考察[J].中国药业,2003,12(10)：29-30.
[9]王锐,朱莉,邓志灏,等.广痛消泡沫气雾剂在人体血浆中的药代动力学研究[J].中国实验方剂学杂志,2013,19(19)：182-186.
[10]张先洪,陆兔林,毛春芹.延胡索不同炮制品镇痛抗炎作用研究[J].时珍国医国药,2009,20(2)：449-450.
[11]鲁春梅,张春森,姜立勇.延胡索化学成分及药理作用研究进展[J]中国现代药物应用,2011,5(15)：126-127.
[12]杨琪伟,杨莉,熊爱珍,等.赤芍和白芍抗炎作用的UPLC-MS代谢组学初步研究[J].中国中药杂志,2011,36(6)：694-697.
[13]吴慧丽,李慧.白芍总苷对溃疡性结肠炎大鼠细胞因子影响的研究[J].中南药学,2010,8(2)：128-131
[14]王洪志,刘朝东,韦超.白芍总苷对慢性非细菌性前列腺炎大鼠TFN-γ,TNF-α和IL-10表达影响的实验研究[J].重庆医科大学学报,2010,35(2)：231-234.
[15]傅宝娣.芍药苷对缺氧损伤人脐静脉内皮细胞的影响[D].山东,山东大学药学院,2007.
[16]王君,夏雪雁,彭仁绣,等.当归多糖对大鼠Kupffer细胞免疫功能的激活作用[J].药学学报,2004,39(3)：168-171.
[17]郭振军,刘莉,张维璐,等.大黄、当归多糖对巨噬细甘露受体作用的研究[J].细胞与分子免疫学杂志,2008,24(5)：514-516.
[18]沈建芬,张又枝,肖军花,等.当归活性部位A3对小鼠巨噬细胞环氧化酶-2活性及基因表达的影响[J].中国药理学通报,2011,27(11)：1574-1577.
[19]Wang JP,Ho TF,Chang LC,et al.Anti-inflammatoryeffect of magnolol,isolated fromMagnolia officinalis,on a 23187-induced pleurisy in mice[J].J Pharm Pharmacol,1995,47(10):857-860.
[20]Teng CM,Chen CC,Ko FN,et al.Two antiplatelet agentsfrom Magnolia officinalis[J].Thromb Res,1988,50(6):757-765.
[21]房海灵,李维林,任冰如,等.薄荷属植物的化学成份及药理研究进展[J].中国药业,2010,19(10)：13-16.
[22]刘兴隆,贾波,黄秀深,等.细辛药理研究概况[J].江苏中医药,2005,26(7)：59-61.
[23]唐家广,袁文,陈会生.不同时间硬膜外应用吲哚美辛对大鼠机械性痛敏的影响[J].中国疼痛医学杂志,2008,14(2)：92-95.
[24]周月明,贾振理.消炎痛栓用于痔术后镇痛观察[J].浙江中西医结合杂志,2006,16(10)：644-645.
[25]李强.吲哚美辛栓用于PPH术后肛门下坠的临床观[J].泰山医学院学报,2013,34(5)：374.
[26]游绍珍.吲哚美辛的临床不良反应及预防[J].现代医药卫生,2007,23(9)：1330-1331.
[27]张琰.吲哚美辛栓不良反应的回顾性分析[J].华西医学,2010,25(3)：576-577.
[28]顾莹,季晖,张云,等.厚参痔疮膏抗炎作用及其机制[J].中国天然药物,2007,5(3)：221-224.
[29]李珍兰,周勇.肛肠止痛散治疗炎性外痔78例[J].中国中医药现代远程交与,2011,9(17)：137.
[30]胡琦.金玄痔科熏洗散治疗炎性外痔65例临床观察[J].世界中西医结合杂志,2010,5(8)：731.
[31]熊永文,王海潮.痔速宁栓治疗内痔的临床及病理组织学研究[J].陕西中医学院学报,1993,16(2);42-43.
[32]Chung YC,Hou YC,Pan AC,Endoglin(CD105) expression in the development of haemorrhoids[J].Eur Clin Invest,2004,34(2):107-112.
[33]韩炜,王振军,赵博,等.痔组织弹性纤维退变和血管生成的机制及其意义[J].中华胃肠外科杂志,2005,8(1)：56-59.
[34]王振军,汤秀英,王东,等.内痔的病理形态改变特征及其意义[J]中华外科杂志,2006,44(3)：177-180.
[35]徐跃军,张端莲,吴惠芬,等.痔疮组织中血管内皮生长因子的表达及意义[J].数理医药学杂志,2007,20(4)：461-462.
[36]刘长宝,鲍银童,金定国.金氏痔疮膏对大鼠肛管静脉从血管内皮细胞生长因子表达的影响[J].中国中西医结合外科杂志,2007,13(3)：267-269.
[37]李胜龙,朴英杰,杨俊明,等.脱出性痔的形态学观察[J].南方医科大学学报,2008,28(1)：136-138.
[38]张东铭.痔病[M].北京：人民卫生出版社,2004：6-19.
[39]鲁兵,刘玉祥,陈勇,等.急性嵌顿性混合痔的病理形态特征[J].军医进修学院学报,2010,31(3)：251-257.
[40]唐淑敏,陆建良,血栓性外痔包膜的临床病理研究[J].甘肃中医,2010,23(10)：21-22.
[41]潘玉荣,赵瑾,常彬,等.软化萎缩剂芍倍液治疗痔的临床及病理学研究[J].中国普通外科杂志,2013,22(4)：516-521.
[42]赵明明,吴丹妮,余晓玲,等.三黄止血胶囊对大鼠肛管静脉丛血管内皮生长因子表达的影响[J].结直肠肛门外科,2013,19(1)：16-18.
[43]张少军,汪庆明,张志君,等.痔血宁合剂对湿热下注证痔病患者MMP-9、VEGF表达的影响[J].上海中医药大学学报,2013,27(5)：52-55.
[44]LappasM,Permezel M,GeorgiouHM,et al.Nuclearfactorkappa B regulation of proinflammatory cytokines in human gestational tissuesin vitro[J].BiolReprod,2002,67(2):668-673.
[45]Crowell JA, Steele VE, Sigman CC, et al. Is inducible nitric oxide synthasea target for chemo preventions[J].Mol Cancer Ther,2003,2(8):815-823.
[46]Vo PA, Lad B,Tomlinson ja,etal.Autoregulatory role of endothelium deliverd nitric oxide(NO) on Leopolysaccharide-induced vascular induciblefunction[J].JBoil Chem,2005280(8):7236-7243.
[47]Heales SJ,Bolanos JP, Stewart VC,et al. Nitric oxide,mitochondria and neurological disease[J]. Biochim BiophysActa,1999,1410(2):215-228.
[48]Torres A, Torres K, Paszkowski T, et al. Cytokine response in the postoperative period after surgical treatment of benign adnexal masses:comparison between laparoscopy and laparotomy[J]. Surg Endosc,2007,21(10):1841-1848.
[49]梁纯波,傅迪,郭曲练,等.脊髓肿瘤坏死因子-alpha (TNF-a)促进切割损伤导致的痛觉过敏[J].现代生物医学进展,2009,9(9)：1635-1637.
[50]Taylor PC,Feldmann M. Anti-TNF biologic agents:still the therapy of choicefor rheumatoid arthritis [J]. Nat Rev Rheumatic,2009,5(10):578-582.
[51]Cohen SP,Bogduk N,Dragovich A,et al. Randomizeddouble-blind,placebocontrolled, dose-response,and preclinical safety study oftransformational epidural etanercept for the treatment ofsciatica [J].Anesthesiology,2009,110(5):1116-1126.
[2]南京中医学院校释.《诸病源候论校释》(下册)[M]一北京：北京人民卫生出版社,1982,954.
[3]吴剑箫,吴春晓,王延峰.痔疮的瘀毒病因病机探究[J].河北中医,2012,34(5)：755-756.
[4]朱震亨.《丹溪心法》[M].北京,北京市中国书店出版,年代卷2：140.
[5]战晓农,余成栋.浅谈古代医家对痔疮病因病机的认识[J].江苏中医药,2006,27(9)：16-17.
[6]申斗垣.《外科启玄》[M].北京,人民卫生出版社,1956,卷7：50.
[7]陈实功.《外科正宗》[M].北京,民卫生出版社,1973,169.
[8]吴谦等.《医宗金鉴》[M].北京,人民卫生出版社,1996,卷69：300.
[9]陈梦雷.《古今图书集成医部全录》[M].北京,人民卫生出版社,1985：227.
[10]赵宝明.新世纪中国肛肠名老中医学术传承与发展战略思考[A].田振国,韩宝.中国肛肠病研究心得集[C].北京：中国古籍出版社,2011：52-532.
[11]王业皇.丁泽明肛肠病治法特点初探[J].南京中医学院学报,1993,9(4)：23-24.
[12]史仁杰.朱秉宜痔科学术经验[J].中医文献杂志,1998,3：38-39.
[13]魏照洲.从瘀论治痔疮[J].四川中医,2006,24(11)：76-77.
[14]皇甫少华,丁曙晴,丁义江.痔中医辨证分型的文献依据[J].吉林中医药,2011,31(12)：1195-1197.
[15]中华中医药学会.中医肛肠科常见病诊疗指南[S].北京：中国中医药出版社,2012：1-4.
[16]韩晓光,包庆慧.痔血的研究进展[J].结直肠肛门外科,2006,12(5)：322-324.
[17]Quenu E. Des arteres du rectum et de I'anus chez I'homme et chez lafemme[J].Bul.Soc.Anat,1893,7:703-708.
[18]Parks AG. HemorrhoidsHosp[J].Rep,1995,104(2):135-156.
[19]张东铭.痔的病因与病理生理学的现代概念[J].中国肛肠病杂志,2001,21(11)：39.
[20]Hunt AH.Discussioon on Portal Hypertension[J]. Proc R socMed,1954,47(6):469-475.
[21]Waddell WG, Bouchard AG, Wellington JL, et al. Functional relations of the proximal components of the portal system,a preliminary report[J]. J Surg Res,1972,12(4):281-289.
[22]Thomson WH. The nature of haemorrhoids[J].Br J Surg,1975,62(7):542-552.
[23]Bernstein WC. What are hemorrhoids and what is their relationship to the portal system[J].Dis Colon Rectum,1983,26(12):829-834.
[24]Shafid A. Aconcept of the anatomy of the anal sphincter mechanism and the physiology of defecation[J].Dis Colon Rectum,1987,30(12):970-82.
[25]张东铭,孟庆有,钱雨根,等.肛门部血管分布[J].中国肛肠病杂志,1986,6(2)：3.
[26]Gass OC,Adams J.Hemorrhoids; etiology and pathology[J].Am J Surg.1950,79:40-43.
[27]Alexander-WilliamsJ,Crapp AR. Conservative management of haemorrhoids[J].Clin Gastroenterol.1975,4(3):595-618.
[28]Stelzner F, Staubesand J,Machleidt H.The corpus cavernosum recti basis of internal hemorrhoids [J]. Langenbecks Arch Klin Chir Ver Dtsch Z ChirJ 962.299:302-312.
[29]Parnand E,Guntz M, Bernard A, et al. Normal macroscopic and microscopic anatomy of the hemorrhoidal vascular system [J]. Arch Fr Mal App Dig,1976,65(7):501-514.
[30]Elsenhammer S.The evaluation of the interal anal Sphinclerolomy Operation of the interal anal sphinclerotomy operation with special reference to anal fissure[J].Surg Gyn Obst,1959,109:583-590.
[31]Hancock BD,Smith K. The internal sphincter and Lord's procedureforhaemorrhoids[J].BrJ Surg,1975,62(10):833-836.
[32]Schweiger M. Method for determining individual contributions of voluntary and involuntary anal sphincters to resting tone[J]. Dis Colon Rectum.1979,22(6):415-416.
[33]Duthie HL, Watts TM. Contribution of the externalanalsphinctertothe pressurezoneintheanal cana[J]. Gut,1965.6:64-68.
[34]Parks AG,Swash M.Ulrich H. Sphincter enervation in anorectal incontinense and rectal proplapse[J].Gut,1977,18(8):656-665.
[35]AlperD,Ram E,Stein GY,et al.Resting anal pressure following hemorrhoidectomyand lateral sphincterotomy[J]. DisColonRectum,2005,48(11):2080-2084.
[36]Chanhan A,Thomas S, Bishnoi PK.et al. Randomizedcontrolled trial toassess the role of raised analpressures in the pathogenesis ofsymptomatic early hemorrhoids[J].Dig Surg,2007,24(1):28-32.
[37]张东铭.痔与盆底动力学关系[J].大肠肛门病外科杂志,2000,6(4)：49-54.
[38]Duthy HL,Gairns FW. Senosory nerve ending and sensation in the anal region of man[J]. Br J Surg,1960,47:585-595.
[30]RoeAM,BartoloDC,VeiiacottKD,et al.Submucosal versus ligation excision haemorrhoidectomy:a comparison ofanal sensation,anal sphinctermanometry and postoperative pain and function[J]. Br J Surg,1987,74(10):948-951.
[40]MillerR,Bartolo DC,Roe A,et al.Anal sensation and the continencemechanism[J].DisColon Rectum,1988,31(6):433-438.
[41]Sleisinger MH,Fordtran JS.Gastrointestinal and liverdisease.Path physiology, diagnosis, management[M]. W.B.Saunders Company.2010:1796.
[42]Burkitt DP. Varicose veins,deep vein thrombosis and hemorrhoids epidemiology and suggested etiology[J].Br Med J,1972,2(2813):556-561.
[43]Read NW,Sun WM. Hemorrhoids constipation and hypertensive analcushions[J].Lancet, 1989,1(8636):610.
[44]JahansonJF, SonnenbergA. Theprevalence of hemorrhoids and chronicconstipation. An epidemiologic study[J]. Gastroenterology,1990,98(2):380-386.
[45]张东铭.痔与便秘[J].中华全科医师杂志,2005,4(7)：403-405.
[46]DelcoF,SormenbergA. Association between hemorrhoids and otherdiagnoses[J].DisColon Rectum,1998,41(12):1534-1542.
[47]张东铭.药物治疗痔病的理论基础[A].田振国,韩宝.中国肛肠病研究心得集[C].北京：中国古籍出版社,2011：83-87.
[48]熊一力,将学俊,刘启功,等.VEGF基因对缺氧诱导的内皮细胞凋亡和坏死的影响[J].上海免疫学杂志,1999,19(6)：358-360.
[49]Mason RB,Pluta RM,Walbridge S,et al. Production of reactive oxygen species after reperfusion in vitro and in vivo:Protective effect of nitric oxide [J]. J Neurosurg,2000,93(1):99-107.
[50]高治平,李波平,黄红林,等.缺氧/复氧损伤对血管内皮细胞NO生成和脂质过氧化物的影响[J].南华大学学报·医学版,2003,31(3)：265-266,285.
[51]陈高阳,刘延庆.一氧化氮与疼痛的研究进展[J].国外医学·麻醉学与复苏分册.2004,25(3)：177-179.
[52]袁伟,张学渊.剪切力对血管内皮细胞的生物学影响[J].重庆医学,2003,32(11)：1490-1492.
[53]Adel MM,Izumo S. Mechanism of endothelial cell shapechange and cytoskeletal remodeling in response to fluid shearstress[J].J Cell Seience,1996,109(Pt4):713-726.
[54]Waters CM.Flow-induced modulation of the permeability of endothelial cells alltured on microcarrier beads[J].J Cellul Physiol,1996,168(2):403-411.
[55]王贵学,罗向东,蔡绍皙,等.内皮细胞代谢剪切作用时间的相关性[J].生物物理学报,1999,15(2)：407.
[56]陈友琴,陈槐卿.不同型式活体切应力对血管内皮细胞生理生化的影响[J].国外医学生物医药工程分册,2000,23(4)：233.
[57]陈玲,张清华,蒋知新.炎症因子对人脐静脉内皮细胞表达血管内皮生长因子及妊娠相关血浆蛋白-A的影响[J].广东医学,2009,30(2)：194-195.
[58]潘志国,耿焱,张剑明.热刺激对体外培养的血管内皮细胞损伤及IL-6、TNF-α释放的影响[J].山东医药,2012,52(3)：32-34.
[59]陈清华,袁肇凯.中医药与血管新生研究进展[J].中国中医药信息杂志,2007,14(8)：89-91.
[60]韩炜,王振军,赵博,等.痔组织弹性纤维退变和血管生成的机制及其意义[J].中华胃肠外科杂志,2005,8(1)：56-59.
[61]徐跃军,张端莲,吴惠芬,等.痔疮组织中血管内皮生长因子的表达及意义[J].数理医药学杂志,2007,20(4)：461-462.
[62]刘长宝,鲍银童,金定国.金氏痔疮膏对大鼠肛管静脉从血管内皮细胞生长因子表达的影响[J].中国中西医结合外科杂志,2007,13(3)：267-269.
[63]牛治君,牛明星.大黄牡丹汤加味治疗嵌顿性内痔30例报告[J].中国中医急症,1994, 3(5)：209-210.
[64]郭永红.麻杏石甘汤加味治疗急性嵌顿痔36例[J].新中医,2002,34(12)：52.
[65]尚锦秀,吴汉泉,李华春,等.急性嵌顿痔的中西医结合治疗[J].中国中西医结合外科杂志,2008,14(2)：112-113.
[66]汤成泳,李娟,何海霞,等.五味痔疮胶囊的抗炎作用研究[J].重庆医学,2011,40(24)：2432-2434.
[67]张庚扬,杜钰生.化痔栓治疗痔疮的临床药理研究[J].天津中医药,2003,20(2)：17-19.
[68]张媛,赵宝明.近十年来国内肛肠病中药栓剂研究概况[J].辽宁中医药大学学报,2014,16(2)：271-271.
[69]韦耀力,胡俊杰.苍耳子熏洗治疗炎性痔102例临床观察[J].中医临床研究,2011,3(3)：29-30.
[70]郭纯艳,魏洪亮.痔洗药Ⅰ号治疗炎性外痔80例临床观察[J].中国肛肠病杂志,2009,29(10)：28-29.
[71]周志成.清热消肿膏外敷治疗炎性痔750例[J].中医药学报,1997,4：6.
[72]李洪杰,孙锋,赵文韬.龙珠软膏外敷治疗炎性外痔42例[J].医药导报,2007,26(10)：1169.
[73]徐红,黄卫国,郭淳.麝香痔疮栓和膏合用保守治疗炎性混合痔的临床研究[J].职业卫生与病伤,2010,25(3)：164-165.
[74]裴穗东.针刺二白穴治疗痔痛49例[J].四川中医,2003,21(9)：78.
[75]赵麦焕,杨淑娥.针刺治疗Ⅲ期环状混合痔[J].中华实用中西医杂志,2005,18(8)：1152-1153.
[76]曹朕笃,杨彦平,李亚东.针刺治疗痔疮19例[J].湖南中医杂志,2004,20(4)：40-41.
[77]陈少明,修治平.挑痔疗法治疗肛肠病[J].中国肛肠病杂志,1995,15(5)：43.
[78]Ramelet AA. Pharmacologic aspects of a plebotropic drug in CVI-associated edema[J]. Angiology,2000,51(1):19-23.
[79]Labrid C. Pharmacologic properties of Daflon 500mg[J].Angiology,1994,45(6Pt2): 524-530.
[80]周璐.地奥司明[J].医药导报,2007,26(10)：1235-1236.
[81]Godeberge P.Daflon 500mg in the treatment of hemorrhoidal disease:a demonstrated efficacy in comparison with placebo[J]. Angiology,1994,45 (6 Pt 2):574-578.
[82]王世文,张颖.地奥司明片治疗痔疮急性发作1100例[J].医药导报,2009,28(1)：76-77.
[83]邓斌,徐飞,邱刚林.地奥司明片用于急性嵌顿痔围手术期46例[J].医药导报,2012,31(5)：631-632.
[84]周学健,袁忠,张兵,等.地奥司明联合硫酸镁坐浴治疗炎性外痔50例[J].江苏医药,2012,38(16)：1971-1971.
[85]周天球.迈之灵治疗内痔83例临床观察[J].中医杂志,2004,48：183.
[86]薛建国,王宇,谷俊朝.喜疗妥、迈之灵治疗急性嵌顿痔疗效观察[J].结直肠肛门外科,2008,14(6)：403-404.
[87]张碧群.太宁栓外用配合迈之灵治疗痔疮78例[J].陕西中医,2010,31(9)：1176.
[88]傅传刚,杨巍,孙建华,等.草木犀流浸液片剂治疗痔的疗效研究[J].中华胃肠外科杂志,2004,7(4)：270-272.
[89]张丽娜,史惠卿,陆国庆.静可福[J].中国新药杂志,2004,13(5)：471-472.
[90]杨新庆,陈朝文.复方银杏叶萃取物胶囊用于痔术后的临床研究[J].大肠肛门病外科杂志,2004,10(1)：44-46.
[91]阮向红.硫酸镁甘油湿敷在嵌顿痔水肿防治中的应用[J].结直肠肛门外科,2008,14(3)：163-165.
[92]陈天杰.高渗葡萄糖治疗痔疮习阵月中临床观察86例[A].符中柱.贵州省中西医结合学会肛肠学会第五届学术交流会暨新技术新进展学习班论文汇编[C].贵州：2012：69.
[93]俞静,花宝,朴炳奎.延胡索乙素对放射所致血管内皮细胞损伤的保护作用[J].中华肿瘤防治杂志,2011,18(8)：584-585.
[94]傅保娣,刘玉娥,张岫美,等.芍药苷对缺氧损伤内皮细胞产生NO、eNOS和细胞粘附分子的影响[J].药物分析杂志,2007,27(4)：555-556.
[95]刘海.痔浴液治疗炎性外痔120例临床观察[J].时珍国医国药.2005,16(5)：408-409.
[96]林锡芬,赖庆勇,钟希文.痔舒息洗剂治疗炎性痔100例[J].江西中医药,2006,37(6)：33-34.
[97]王伟军,刘行稳.自拟外洗方治疗炎性外痔的临床观察[J].湖北中医杂志,2006,28(5)：42.
[98]杜文敏,周小燕,郑雄彦.中药熏洗坐浴治疗炎性外痔的疗效观察[J].当代护士(学术版),2007,54(5)：81-82.
[99]李国栋.痔炎宁熏洗剂治疗痔疮85例[J].中医研究,2008,11(9)：32-34.
[100]王艳辉.自拟中药汤剂外洗治疗炎性痔疗效观察[J].中国现代药物应用,2009,3(11)：123.
[101]曹宇,葛昌甫.痔瘘袋泡洗剂治疗炎性痔的临床观察[J].吉林医学,2010,31(5)：615-616.
[102]李浩.中药汤剂外洗保守疗法治疗炎性痔疗效分析[J].中国现代药物应用,2010,4(15)：15-16.
[103]田社清,刘行稳.消肿祛痔汤治疗炎性痔临床观察[J].中西医结合研究,2010,2(1)：15-17.
[104]赵壁.外洗法治疗炎性痔疮80例临床观察[J].健康必读(下半月),2011(10)：250.
[105]刘世茹,陈敏,郝秀艳,等.中药苦参汤加减熏洗治疗炎性外痔的临床观察[J].西部医学,2011,23(9)：1745-1746.
[106]李晓华,张重阳,邢志勇,等.自拟消肿止痛汤熏洗配合金黄膏外敷治疗炎性外痔70例[J].中国中医急症,2011,20(1)：149.
[107]李洋,梁劲军.芒硝外洗方治疗炎性外痔60例[J].中医研究,2011,24(3)：12-14.
[108]刘忠.中药痔瘘洗剂坐浴治疗炎性外痔48例[J].内蒙古中医药,2013,32(20)：16.
[109]王爱华.中药外洗治疗炎性痔疮45例[J].河南中医,2013,33(6)：928-929.
[110]刘成伟,潘素滢.痔宁熏洗冲剂治疗炎性痔106例临床观察[J].新中医,2003,35(4)：25-26.
[111]赵宝明.正确掌握经典痔切除手术[A].田振国、韩宝.中国肛肠病研究心得集[C].中国古籍出版社：中华中医药学会,2011,95-96.
[112]赵宝明,张书信.固脱法与PPH术联合应用的临床研究[A].刘学彦、车名海、王华.中华中医药学会第十二次大肠肛门病学术会议论文汇编[C].中国吉林：中华中医药学会,2006,488-490.
[113]赵宝明,王艳逊,廖培辰,等.中医外科固脱法治疗脱肛溯源及临床应用[J].北京中医,2007,26(7);402-404.
[114]廖培辰.中医外治固脱法治疗脱肛(直肠脱垂)疗效观察[D].北京：北京中医药大学,2005.
[115]彭俊付.中医外治注射固脱法治疗直肠前突疗效观察[D].北京：北京中医药大学,2007.
[116]王锐.中医外治固脱法与PPH术联合应用治疗直肠粘膜内脱垂临床观察[D].北京：北京中医药大学,2007.
[117]易其星.中医固脱法联合松解术治疗PRS+IRP型便秘的临床观察[D].北京：北京中医药大学,2010.
[118]张书信,赵宝明.综合固脱法在盆底疾病治疗中的应用[A].田振国、韩宝.中国肛肠病研究心得集[C].中国古籍出版社：中华中医药学会,2011,297-298.
[119]赵宝明.中医外治固脱法硬化阻断防治肿瘤[A].田振国、韩宝.2012医学前沿——中华中医药学会肛肠分会第十四次全国肛肠学术交流大会论文精选[C].中国古籍出版社：中华中医药学会,2012,334-338.
[120]赵宝明,史兆岐,景建中.广痛消泡沫气雾剂对肛门直肠疾病止痛作用的临床研究[J].中医杂志,1998,39(7)：412.
[121]吴振宇,吴广均,赵宝明.广痛消泡沫气雾剂的止痛解痉作用[J].中国中药杂志,2001,26(8)：559-561.
[122]酒淑玲.广痛消泡沫气雾剂促进混合痔术后创面愈合的临床研究[D].北京.北京中医药大学,2011.
[123]彭俊付.广痛消泡沫气雾剂经直肠粘膜渗透率试验研究及其止痛与安全性临床观察[D].北京.北京中医药大学,2011.
[214]赵宝明,张志谦,张书信等.广痛消泡沫气雾剂止血抗炎作用实验研究[J].中华中医药学刊,2011,29(10)：2164-2165.
[125]葛小栋.广痛消泡沫气雾剂治疗混合痔术后水肿的临床研究[D].北京.北京中医药大学,2012.
[126]张志谦,赵宝明,张书信等.广痛消泡沫气雾剂止痛促愈合的实验研究[J].中国中医药信息杂志,2012,19(3)：33-35.
[127]张志谦.广痛消泡沫气雾剂治疗混合慢性肛裂的疗效观察和机制研究[D].北京.北京中医药大学,2012.
[128]陈浩漩.广痛消泡沫气雾剂治疗内痔便血脱垂及痨核黏膜修复的临床研究[D].北京.北京中医药大学,2013.
[129]王锐,朱莉,邓志灏,等.广痛消泡沫气雾剂在人体血浆中的药代动力学研究[J].中国实验方剂学杂志,2013,19(19)：182-186.
[130]张媛,赵宝明.广痛消泡沫气雾剂对大鼠肛门水肿模型肿瘤坏死因子-a和白细胞介素6的影响[J].2014,22(2)：94-95.
[131]白邈.赵宝明治疗便秘经验[J].中医杂志,2012,53(23)：2047-2048.
[132]谢海洲,杨增良.谢海洲教授治疗脑髓病的经验[J].河南中医,2003,23(12)：16-17.
[1]陈奇.中药药理研究方法学[M].第三版.北京：人民卫生出版社,2011.
[2]国家中医药管理局《中华本草》编委会.中华本草(第4册).上海：上海科学技术出版社,1999：769.
[4]钱伯初,史红,郑晓亮.痔疮动物模型制作方法研究进展[J].中国比较医学杂志,2007,17(2)：119-122.
[5]赵宝明,史兆岐,景建中.广痛消泡沫气雾剂对肛门直肠疾病止痛作用的临床研究[J].中医杂志,1998,39(7)：412.
[6]鲁春梅,张春森,姜立勇,等.延胡索化学成分及药理作用研究进展[J].中国现代药物应用,2011,5(15)：126-127.
[7]李杰萍,梁统,周克元.厚朴酚对大鼠白细胞5-脂氧合酶活性和细胞内钙离子浓度的影响[J].广东医学院学报,2002,20(3)：177-178.
[8]Chaplan SR,Bach FW,Pogrel M,et al.Quantitativeassessment of tactile allodynia in the rat paw[J]. J Neurosci Meth,1994,53(1):55-63.
[9]Hargreaves K,Du bner R,Nolan P,et al. Anew and sensitive method for measuring thermal nociception in cutaneous hyperalgesia[J].Pain,1988,32(1):77-88.
[10]傅开元,Alan R. Light, William Maixner.外周炎症性疼痛刺激诱发中枢神经系统小胶质细胞增殖活化[J].中国神经免疫学和神经病学杂志,2001,8(3)；179-181.
[11]Deleo JA, Colburn RW, Nichols M,et al.Interleukin-6-mediated hyperalgesia allodynia and increased spinal IL-6 expression in a rat mononeuropathy model [J]. J Interferon Cytokine Res,1996,16(9):695-700.
[12]Deleo JA,Colburn RW,Rickman AJ.Cytokine and growth factor immune histochemical spinal profiles in two animal models of mononeuropathy [J].Brain Res,1997,759(1):50-57.
[13]张志谦.广痛消泡沫气雾剂治疗混合慢性肛裂的疗效观察和机制研究[D].北京.北京中医药大学,2012.
[14]王玮,张雪非.爆炸伤创面IL-1、IL-6、TNF-α、CRP的测定[J].中国矫形外科杂志,2007,15(18)：1418-1419.
[15]RaghavendraV,Tanga FY, DeLeo JA.Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS[J]. European Journal of Neuroscience,2004,20(2):467-473.
[16]Cata JP, Weng HR, Dougherty PM. Cyclooxygenase inhibitors and thalidomide ameliorate vincristine-induced hyperalgesia in rats[J]. Cancer Chemother Pharmacol, 2004,54(5):391-397.
[17]Watkins LR,Milligan ED,Maier SF. Glial proinflammatory cytokines mediate exaggerated pain states:implications for clinical pain[J]. Advances in Experimental Medicine & Biology,2003;521:1-21.
[18]赵福涛,丁元晶.白芍总苷在风湿免疫性疾病中的应用进展[J].中国医院药学杂志,2006,26(12)：1546-1548.
[19]郭振军,刘莉,张维璐,等.大黄、当归多糖对巨噬细胞甘露受体作用的研究[-J].细胞与分子免疫学杂志,2008,24(5)： 514-516.
[20]杨周平,武志军.中药黄柏的药理作用和临床应用研究[J].甘肃医药,2010,29(3)：329-331.
[21]Remmele W, Stegner HE.Recomendation for uniform definition of an immunoreactive score(IRS) for immunohistochemical estrogen receptor detection(ER-CIA) in breast cancer tissue[J].Pathology,1987,8(3):138-140.
[22]Elfering SL,Sarkela TM,Giulivi C.Biochemistry of mitochondrial nitric-oxide synthase[J].J Biol Chem,2002,277(41):38086-38097.
[23]PanaroMA,BrandonisioO,AcquafreddaA,etal.EvidencesforiNOS Expression and nitricoxideproductioninthehumanmacrophages[J].CurrDrugTargetsImmuneEndocrMetabolDi sord,2003,3(2):210-221.
[24]Heales SJ,Bolanos JP,Stewart VC,et al. Nitric oxide,mitochondria and neurological disease[J].Biochim BiophysActa,1999,1410(2):215-228.
[25]Tao F,Tao Y X, Mao P,et al.Intact carrageenaninducedthermal hyperalgesia in mice lacking inducible nitric oxidesynthase[J].Neuroscience,2003,120(3):847-854.
[26]金宏波,徐洪伟,刘军.一氧化氮合酶抑制剂L-NNA对福尔马林大鼠脑nNOS.iNOS表达的影响[J].2004,38(5)：407-410.
[27]陈维娜.大鼠甲醛炎性痛时脊髓nNOS和iNOS的表达及胶质细胞抑制剂的影响[D].河北.河北医科大学,2004.
[1]中华医学会外科学分会结直肠肛门外科学组,中华中医药学会肛肠病专业委员会,中国中西医结合学会结直肠肛门病专业委员会.痔临床诊治指南(2006版).中华胃肠外科杂志,2006,9(5)：461-463.
[2]中华中医药学会.中医肛肠科常见病诊疗指南[S]一北京；中国中医药出版社,2012：1-4.
[3]胡金花.肛肠病术后使用消炎痛栓的临床观察及护理[J].上海护理,2002,2(3)：32-33.
[4]张国宝.普济痔疮栓治疗痔疮的临床效果分析[J].中医临床研究,2013,5(6)：61-63.
[5]Richman M D,Shangraw R E.Foams[J].Aerosol Age,1966,11:127.
[6]酒淑玲.广痛消泡沫气雾剂促进混合痔术后创面愈合的临床研究[D].北京.北京中医药大学,2011.
[7]徐逢辰.醋酸氢化可的松泡沫及直肠内给药的临床研究[J].国外医学参考资料,1976,2：86.
[8]徐建军,李鸿进,孟敏.复方醋酸氢化可的松泡沫剂的稳定性考察[J].中国药业,2003,12(10)：29-30.
[9]王锐,朱莉,邓志灏,等.广痛消泡沫气雾剂在人体血浆中的药代动力学研究[J].中国实验方剂学杂志,2013,19(19)：182-186.
[10]张先洪,陆兔林,毛春芹.延胡索不同炮制品镇痛抗炎作用研究[J].时珍国医国药,2009,20(2)：449-450.
[11]鲁春梅,张春森,姜立勇.延胡索化学成分及药理作用研究进展[J]中国现代药物应用,2011,5(15)：126-127.
[12]杨琪伟,杨莉,熊爱珍,等.赤芍和白芍抗炎作用的UPLC-MS代谢组学初步研究[J].中国中药杂志,2011,36(6)：694-697.
[13]吴慧丽,李慧.白芍总苷对溃疡性结肠炎大鼠细胞因子影响的研究[J].中南药学,2010,8(2)：128-131
[14]王洪志,刘朝东,韦超.白芍总苷对慢性非细菌性前列腺炎大鼠TFN-γ,TNF-α和IL-10表达影响的实验研究[J].重庆医科大学学报,2010,35(2)：231-234.
[15]傅宝娣.芍药苷对缺氧损伤人脐静脉内皮细胞的影响[D].山东,山东大学药学院,2007.
[16]王君,夏雪雁,彭仁绣,等.当归多糖对大鼠Kupffer细胞免疫功能的激活作用[J].药学学报,2004,39(3)：168-171.
[17]郭振军,刘莉,张维璐,等.大黄、当归多糖对巨噬细甘露受体作用的研究[J].细胞与分子免疫学杂志,2008,24(5)：514-516.
[18]沈建芬,张又枝,肖军花,等.当归活性部位A3对小鼠巨噬细胞环氧化酶-2活性及基因表达的影响[J].中国药理学通报,2011,27(11)：1574-1577.
[19]Wang JP,Ho TF,Chang LC,et al.Anti-inflammatoryeffect of magnolol,isolated fromMagnolia officinalis,on a 23187-induced pleurisy in mice[J].J Pharm Pharmacol,1995,47(10):857-860.
[20]Teng CM,Chen CC,Ko FN,et al.Two antiplatelet agentsfrom Magnolia officinalis[J].Thromb Res,1988,50(6):757-765.
[21]房海灵,李维林,任冰如,等.薄荷属植物的化学成份及药理研究进展[J].中国药业,2010,19(10)：13-16.
[22]刘兴隆,贾波,黄秀深,等.细辛药理研究概况[J].江苏中医药,2005,26(7)：59-61.
[23]唐家广,袁文,陈会生.不同时间硬膜外应用吲哚美辛对大鼠机械性痛敏的影响[J].中国疼痛医学杂志,2008,14(2)：92-95.
[24]周月明,贾振理.消炎痛栓用于痔术后镇痛观察[J].浙江中西医结合杂志,2006,16(10)：644-645.
[25]李强.吲哚美辛栓用于PPH术后肛门下坠的临床观[J].泰山医学院学报,2013,34(5)：374.
[26]游绍珍.吲哚美辛的临床不良反应及预防[J].现代医药卫生,2007,23(9)：1330-1331.
[27]张琰.吲哚美辛栓不良反应的回顾性分析[J].华西医学,2010,25(3)：576-577.
[28]顾莹,季晖,张云,等.厚参痔疮膏抗炎作用及其机制[J].中国天然药物,2007,5(3)：221-224.
[29]李珍兰,周勇.肛肠止痛散治疗炎性外痔78例[J].中国中医药现代远程交与,2011,9(17)：137.
[30]胡琦.金玄痔科熏洗散治疗炎性外痔65例临床观察[J].世界中西医结合杂志,2010,5(8)：731.
[31]熊永文,王海潮.痔速宁栓治疗内痔的临床及病理组织学研究[J].陕西中医学院学报,1993,16(2);42-43.
[32]Chung YC,Hou YC,Pan AC,Endoglin(CD105) expression in the development of haemorrhoids[J].Eur Clin Invest,2004,34(2):107-112.
[33]韩炜,王振军,赵博,等.痔组织弹性纤维退变和血管生成的机制及其意义[J].中华胃肠外科杂志,2005,8(1)：56-59.
[34]王振军,汤秀英,王东,等.内痔的病理形态改变特征及其意义[J]中华外科杂志,2006,44(3)：177-180.
[35]徐跃军,张端莲,吴惠芬,等.痔疮组织中血管内皮生长因子的表达及意义[J].数理医药学杂志,2007,20(4)：461-462.
[36]刘长宝,鲍银童,金定国.金氏痔疮膏对大鼠肛管静脉从血管内皮细胞生长因子表达的影响[J].中国中西医结合外科杂志,2007,13(3)：267-269.
[37]李胜龙,朴英杰,杨俊明,等.脱出性痔的形态学观察[J].南方医科大学学报,2008,28(1)：136-138.
[38]张东铭.痔病[M].北京：人民卫生出版社,2004：6-19.
[39]鲁兵,刘玉祥,陈勇,等.急性嵌顿性混合痔的病理形态特征[J].军医进修学院学报,2010,31(3)：251-257.
[40]唐淑敏,陆建良,血栓性外痔包膜的临床病理研究[J].甘肃中医,2010,23(10)：21-22.
[41]潘玉荣,赵瑾,常彬,等.软化萎缩剂芍倍液治疗痔的临床及病理学研究[J].中国普通外科杂志,2013,22(4)：516-521.
[42]赵明明,吴丹妮,余晓玲,等.三黄止血胶囊对大鼠肛管静脉丛血管内皮生长因子表达的影响[J].结直肠肛门外科,2013,19(1)：16-18.
[43]张少军,汪庆明,张志君,等.痔血宁合剂对湿热下注证痔病患者MMP-9、VEGF表达的影响[J].上海中医药大学学报,2013,27(5)：52-55.
[44]LappasM,Permezel M,GeorgiouHM,et al.Nuclearfactorkappa B regulation of proinflammatory cytokines in human gestational tissuesin vitro[J].BiolReprod,2002,67(2):668-673.
[45]Crowell JA, Steele VE, Sigman CC, et al. Is inducible nitric oxide synthasea target for chemo preventions[J].Mol Cancer Ther,2003,2(8):815-823.
[46]Vo PA, Lad B,Tomlinson ja,etal.Autoregulatory role of endothelium deliverd nitric oxide(NO) on Leopolysaccharide-induced vascular induciblefunction[J].JBoil Chem,2005280(8):7236-7243.
[47]Heales SJ,Bolanos JP, Stewart VC,et al. Nitric oxide,mitochondria and neurological disease[J]. Biochim BiophysActa,1999,1410(2):215-228.
[48]Torres A, Torres K, Paszkowski T, et al. Cytokine response in the postoperative period after surgical treatment of benign adnexal masses:comparison between laparoscopy and laparotomy[J]. Surg Endosc,2007,21(10):1841-1848.
[49]梁纯波,傅迪,郭曲练,等.脊髓肿瘤坏死因子-alpha (TNF-a)促进切割损伤导致的痛觉过敏[J].现代生物医学进展,2009,9(9)：1635-1637.
[50]Taylor PC,Feldmann M. Anti-TNF biologic agents:still the therapy of choicefor rheumatoid arthritis [J]. Nat Rev Rheumatic,2009,5(10):578-582.
[51]Cohen SP,Bogduk N,Dragovich A,et al. Randomizeddouble-blind,placebocontrolled, dose-response,and preclinical safety study oftransformational epidural etanercept for the treatment ofsciatica [J].Anesthesiology,2009,110(5):1116-1126.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |